CONTEXT: Unbalanced subtelomeric chromosomal rearrangements are often associated with intellectual disability (ID) and malformation syndromes. The prevalence of such rearrangements has been reported to be 5-9% in ID populations. AIMS: To study the prevalence of subtelomeric rearrangements in the Indonesian ID population.
Introduction
The genetic causes of intellectual disability (ID) comprise (sub) microscopically chromosome abnormalities and monogenic diseases. [1] Microscopically visible numerical and structural abnormalities are the most common cause of ID. In a large meta-analysis review, a median rate of 9.5% was described. [2] Apart from these microscopically visible chromosomal abnormalities, there are submicroscopic abnormalities that cannot be detected by conventional karyotyping. Abnormalities in the most distal ends of chromosomes, which harbor the highest gene concentrations in the human genome, [3] are difficult to identify on routine chromosome analysis while they represent an important genetic cause of idiopathic ID. Therefore, testing for such rearrangements has turned out to be an important clinical evaluation step in the etiological diagnosis of unexplained ID cases. [4] In several studies, subtelomeric rearrangements were found to be associated with moderate to severe phenotypic abnormalities and turned out to be a significant cause of ID, with an estimated prevalence of 5-9% of cases in various populations. [5] [6] [7] To date, however, there are no data about the prevalence of subtelomeric rearrangements in Indonesia.
In a large number of Indonesian ID patients, the cause of ID could be established by conventional karyotyping or molecular testing for fragile X syndrome (FXS), but the majority of cases still remained unexplained. [8] Therefore, this study aimed at determining the prevalence of subtelomeric rearrangements and the clinical features in these ID individuals in Indonesia.
Materials and Methods
This research is an extension of previously reported studies on the identification of genetic causes of ID in Indonesia, where chromosomal aberrations and FXS were investigated in a large cohort of 527 Indonesian ID individuals from several special schools and institutions in Java Island, Indonesia. These previous studies revealed chromosomal abnormalities in 82 individuals and FXS in 9 individuals. [8, 9] In the present study, molecular testing of subtelomeric deletions and duplications was performed in the 436 as yet unresolved patients (278 males and 158 females). Informed consent was obtained from the parents or legal representatives, and the study has been approved by the Ethical Board of our institute. All subjects underwent a standardized clinical examination including physical measurements and dysmorphological assessment.
The DNA was isolated from peripheral blood using the salting out extraction procedure as described elsewhere. [10] Multiplex ligation dependent probe amplification (MLPA) analysis was performed as described previously. [11] Two probe-kits for subtelomeric chromosomal imbalances were used in these experiments: SALSA P070 and SALSA P036D MRC-Holland, Amsterdam, The Netherlands (http://www. mrc-holland.com). Each subtelomeric rearrangement was identified by at least one additional MLPA analysis using the SALSA P070 as the first level screening. Afterwards, SALSA P036D was utilized for confirmation of the aberration detected with the P070 kit. Rearrangements in specific regions were verified with SALSA kit P028, P023B, P340A or P096. The detail of regions detected by each kit is available at http://www.mlpa.com. Amplification products were identified and quantified by capillary electrophoresis on an ABI 3730 genetic analyzer (Applied Biosystems, Foster City, CA, USA) using GeneMapper Software version 3.7 (Apache Software; http://www.apache.org), manufacturer (University of Tokyo). Statistical analyses were carried out using Microsoft ® Excel spreadsheets as described before. [12] The results were considered abnormal when the relative peak height ratio was below 0.70 or above 1.30.
When a deletion or duplication was detected in both MLPA kits, parents were tested for de novo occurrence.
When parental DNA was not available, additional methodologies were performed for confirmation of the presence of the detected deletion or duplication. (University of Tokyo). [13] The clinical data of all patients were reviewed and compared to other cases with a comparable aberration, described in the literature.
Results
The initial screening with the SALSA P070 probe kit showed a subtelomeric deletion and/or duplication in 23 of the 436 ID individuals [ Table 1 ]. In 20 of these samples, the presence of the aberration could be confirmed by the SALSA P036D kit [cases 1-20, Table 1 ], while in the three remaining cases, this was not possible and they were considered to be either artefacts or non-causative variants. Parental testing was possible in eight of the 20 cases (cases 1-8) and revealed a de novo occurrence of the subtelomeric imbalances in five cases (cases 1-4 and 6). These five aberrations were, therefore, considered being pathogenic [ Tables 1 and 2 ]. The phenotypes of cases 1 and 2 share many similarities with known cases with monosomy 18pter [14] or a subtelomeric duplication of 9p24, [15] respectively. In cases 3, 4, and 5, a subtelomeric deletion appeared to be coexistent with a subtelomeric duplication, which implicates the presence of a cryptic unbalanced translocation. The phenotype of case 3 was comparable to reported cases with either a 4p duplication [14] or a 18p deletion. [16] Therefore, either dup 4pter or deletion 18pter (or both) could be contributing to the phenotype in the case 3. In case 4, the phenotype is most likely due to the deletion of 10pter, because of the phenotypic overlap with previously reported cases with a deletion of 10p15. [17] The dysmorphic features of this case do not match the clinical description of another individual with a duplication of 9pter [15] In case 5, the 9pter/ qter deletion/duplication is considered to be causative.
The clinical details have been reported elsewhere. [18] In case 6, a de novo deletion of the X/Yqter pseudo autosomal region 2 was detected, which was previously also described in phenotypically normal individuals (DGV;
http://www.tcag.ca/). Therefore, we performed an additional SNP array analysis to enable a fairly precise determination of the size of the deletion and link it to the severity of the clinical features. To our surprise, this revealed a 2 Mb deletion on chromosome 22q11 that has previously been described in patients with a similar phenotype. [19] We therefore, conclude that the phenotype of case 6 is not due to the de novo X/Yqter deletion, but due to the 22q11 deletion.
In two cases (case 7 and 8), parental testing showed that the aberration was inherited from an unaffected parent. These aberrations were therefore, considered being familial variants that do not contribute to the phenotype in case 7 and 8. When parental samples were not available, we tried to confirm the presence of the detected subtelomeric aberration using additional methodologies [ Table 1 ] [20, 21] we suggest that in case 10, both duplications contribute to the phenotype.
In cases 11 and 12, a subtelomeric deletion of 9pter was identified. Case 11 showed a milder phenotype than previously reported cases. [22, 23] In order to see, if the deletion in case 11 was smaller than the deletions reported before, SNP array analysis was performed.
The deletion appeared to be 11.8 Mb in size, and it does not exceed the critical region of 9p syndrome; [22, 23] this, therefore, explained the mild phenotype. In case 12, however, the patient showed some similarities to the reported cases. [22] Therefore, it is suggested that 9pter deletion in case 12 is causative, and array analysis to determine the actual size of the deletion was unnecessary.
In case 13, a microduplication of 15q11 was identified.
MLPA analysis of probes in the 15q11.2-15q15.1 region (MRC Holland kit P028) showed a duplication of the probes between breakpoint 1 and breakpoint 3 (including TUBGCP5 and APBA2). The methylation specific analysis indicated that the interstitial duplication was of maternal origin. It is suggested, that the duplication explains mild ID and minor dysmorphic features in case 13, since duplications of 15q11 are associated with a highly variable phenotype. [24] In cases 14-20, parental testing and additional testing were not performed. This was due to the fact that in some cases, materials for additional testing were unavailable. Another reason was that the clinical features of the patient showed some similarities to the reported cases; therefore, additional testing was considered unnecessary. In case 14, a subtelomeric deletion of 2qter was identified. This patient showed shortening of the metacarpal bones which occurs in the majority of 2q37 patients. [25] It is suggested, therefore that the deletion in this case is causative. In case 15, a subtelomeric and idiopathic short stature (ISS). [26, 27] A duplication of 11pter has been reported in a case of Silver-Russell syndrome. [28] Therefore, both the dup 11pter and the deletion Xpter could be contributing to the short stature of this individual's phenotype.
In reviewed all previously reported cases as well as cases with pure cytogenetic deletion of 12pter and duplication of 12qter. [29] Compared to these previously reported cases with larger abnormalities, our patient showed a milder phenotype such as minor facial dysmorphisms and mild ID [ Table 2 ]. It is suggested that the terminal duplication/deletion of chromosome 12 in this patient was smaller than previously reported and could contribute to the phenotype.
In case 17, a subtelomeric deletion of 8pter was identified. He showed mild ID with minor facial dysmorphisms. A subtelomeric 8pter deletion is rare, and only few cases have been reported. [4] Wu In case 18, a duplication of the probes in the SHOX gene in the pseudo-autosomal region 1 (PAR1)
Xpter/Ypter was identified. SHOX duplications limited to PAR1 appear to be rare, and the associated phenotype is highly variable. [30, 31] SHOX gene defects, either a deletion or duplication, were associated with LWD and ISS. It has to be noted; however, that the effect of a duplication is ambiguous. [27] Consequently, the clinical features associated with such duplication were likely to be under-ascertained. [30] We are uncertain, therefore, whether the duplication of this gene contributed to the clinical phenotype or not.
In cases 19 and 20, a subtelomeric duplication of 16qter was identified. A 16qter submicroscopic microduplication is rarely reported. Ravnan et al. (2006) reported five cases with a duplication 16qter in which the duplicated signal was adjacent to the 18p subtelomere probe signal. In two cases, the recombination appeared to be inherited from unaffected parents, and these were considered to be variants. Therefore, in the other three cases the recombination was also regarded to be a variant although parental samples were not available. [32] It cannot be ruled out; however, that the duplication in cases 19 and 20 are contributing to their phenotype since 16qter is a gene-rich region. More than ten genes are present in the ~500 kb proximal to 16qter. Some of these (NULP1, TUBB3, and AFG3L1) are expressed in the brain, [33] and it is possible that overexpression of these genes contributes to ID.
Discussion
This is the first study identifying subtelomeric chromosomal aberrations in Indonesian ID individuals. [32] and 4.4% as reported by van Karnebeek et al. [2] Five individuals (5/16; 31%) are suggested to have an unbalanced translocation that was not detected by routine cytogenetic analysis. In three of these, the translocation was shown to be de novo (case 3, case 4, and case 6), whereas in the two others, parental samples were unavailable. The prevalence of these cryptic imbalances in our ID population is in the range of a previous study conducted by Wu et al. (2010) , who reported such rearrangements in 21.7% (5/23) and the study of Jehee et al. (2011) which reported such rearrangements in 42.1% (8/19 ). [6, 7] The considerably high rate of unbalanced translocations observed in this study might be explained by the fact that we did not use high-resolution banding, which could have detected most "cryptic" subtelomeric anomalies. [8] Although the MLPA method is capable of revealing subtelomeric rearrangements, the clinical significance of each rearrangement should be interpreted carefully, particularly for cases in which the clinical features are different from previously reported cases. In case 6, for example, the de novo subtelomeric X/Yqter deletion could not explain the clinical features when compared to the previously reported cases. [32, 34] Furthermore, in the DGV it is reported that rearrangements in this region can be detected in phenotypically normal individuals as well.
Subsequent SNP array in this patient identified another abnormality, which explained his clinical phenotype.
To conclude, this is the first large-scale study of the detection of submicroscopic subtelomeric aberrations in Indonesian patients with ID. This study shows that subtelomeric rearrangements are an important cause of ID in Indonesia, and its prevalence does not differ from previously reported studies in the Western world.
Since diagnostic facilities for this kind of abnormalities
are not yet available in Indonesia, the implementation of this technique in a routine diagnostic setting will help to establish a genetic diagnosis in individuals with ID, and will improve the possibilities for genetic counseling to the families involved. To establish an adequate diagnosis is of crucial importance for patients and their families.
Therefore, diagnostic facilities for genetic diseases need to get a higher priority in Indonesia, similar to those for common infectious diseases and nutritional problems.
